383TiP - Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)
Autor: | Litton, J.K., Damodaran, S., Wistuba, I.I., Yang, F., Contreras, A., Tam, A., Ojalvo, L., Dussault, I., Helwig, C., Moulder, S. |
---|---|
Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v139-v139 |
Databáze: | ScienceDirect |
Externí odkaz: |